Eupraxia Pharmaceuticals   Report issue

For profit Phase 2
Founded: Victoria BC United Kingdom (2012)

Organization Overview

First Clinical Trial
2016
NCT02609126
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Eupraxia Pharmaceuticals | Eupraxia Pharmaceuticals Inc.